[1]
“Azithromycin: characteristics and clinical indications for bacterial and virus infections, including SARS-CoV-2 infections ”, RSD, vol. 10, no. 12, p. e381101219864, Sep. 2021, doi: 10.33448/rsd-v10i12.19864.